Figure 2From: The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapyPrognostic value of ProANP and ProAVP in CAP. ProANP and proAVP at levels below 116 pmol/l and 28.8 pmol/l, respectively, are predictive of survival in CAP patients over a 30-day period. Reproduced with permission from Krüger and coworkers [11]. CAP, community-acquired pneumonia; proANP, pro-atrial natriuretic peptide; proAVP, pro-vasopressin.Back to article page